MEDADVISO Stock Australian S.E.
Equities
Advanced Medical Equipment & Technology
Sales 2024 * | 121M 80.97M 111M | Sales 2025 * | 144M 95.9M 131M | Capitalization | 275M 183M 251M |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | 3M 2M 2.73M | EV / Sales 2024 * | 2.19 x |
Net cash position 2024 * | 8.75M 5.83M 7.97M | Net cash position 2025 * | 15.05M 10.03M 13.71M | EV / Sales 2025 * | 1.81 x |
P/E ratio 2024 * |
746
x | P/E ratio 2025 * |
107
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.77% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Ratliff
CEO | Chief Executive Officer | - | 22-07-14 |
Ancila Desai
DFI | Director of Finance/CFO | - | 22-10-16 |
Craig Schnuriger
CTO | Chief Tech/Sci/R&D Officer | - | 20-06-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Linda Jenkinson
CHM | Chairman | - | 22-02-27 |
Kevin Hutchinson
BRD | Director/Board Member | - | 22-11-22 |
Richard Ratliff
CEO | Chief Executive Officer | - | 22-07-14 |
1st Jan change | Capi. | |
---|---|---|
-4.94% | 29.58B | |
+49.49% | 9.98B | |
+34.36% | 4.4B | |
-42.11% | 2.19B | |
-9.44% | 1.6B | |
-28.06% | 1.24B | |
-42.92% | 978M | |
+8.65% | 972M | |
-47.18% | 735M |